period,total_demand,total_supply,shortage_amount,unsold,shortage_percentage,disrupted_manufacturers,fda_announcement
0,1.2,0.7,0.5,0,0.4166666666666667,[0],
1,1.3,0.7,0.6000000000000001,0,0.46153846153846156,[0],The FDA is closely monitoring the current emerging drug shortage and encourages manufacturers and healthcare providers to report any supply issues or disruptions. We are committed to facilitating coordination to minimize patient impact.
2,1.5,0.8500000000000001,0.6499999999999999,0,0.4333333333333333,[0],The FDA is monitoring an emerging shortage situation. We encourage manufacturers to report supply issues and coordinate with each other and the FDA to stabilize the market. Stakeholders are advised to avoid unnecessary stockpiling to ensure equitable distribution.
3,1.5,0.8500000000000001,0.6499999999999999,0,0.4333333333333333,[0],"The FDA acknowledges the emerging drug shortage and encourages stakeholders to report supply issues and increase coordination efforts. Patient safety remains our priority, and we urge manufacturers to explore capacity expansions to address the current disruptions."
